Trials / Sponsors / MCM Vaccines B.V.
MCM Vaccines B.V.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Prev Hepatitis B, Pertussis | Phase 3 | 2016-04-26 |
| Completed | Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010) Neisseria Meningitidis, Bacterial Infections, Virus Diseases | Phase 3 | 2013-05-01 |
| Completed | Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011) Neisseria Meningitidis, Bacterial Infections, Virus Diseases | Phase 3 | 2012-03-30 |
| Completed | Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V Bacterial Infections, Virus Diseases | Phase 3 | 2011-11-23 |
| Completed | Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419- Bacterial Infections, Virus Diseases | Phase 3 | 2011-05-26 |